Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Jun 27, 2025; 17(6): 104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Published online Jun 27, 2025. doi: 10.4240/wjgs.v17.i6.104545
Table 3 Misjudgment rate of predicting the efficacy of neoadjuvant chemotherapy for gastric cancer using different texture feature selection and classification analysis methods in computed tomography images
Discrimination methods | RDA misclassification rate (%) | PCA misclassification rate (%) | LDA misclassification rate (%) | NDA misclassification rate (%) |
Venous phase | ||||
Fisher | 21.86 | 18.45 | 14.92 | 11.53 |
POE + ACC | 19.75 | 16.82 | 13.45 | 9.86 |
MI | 18.32 | 15.46 | 11.85 | 8.92 |
FPN | 17.53 | 14.25 | 10.63 | 7.85 |
Arterial phase | ||||
Fisher | 25.92 | 22.85 | 19.46 | 16.85 |
POE + ACC | 24.53 | 21.46 | 18.25 | 15.42 |
MI | 22.85 | 19.75 | 16.92 | 14.53 |
FPN | 21.46 | 18.53 | 15.86 | 13.92 |
- Citation: Wang CY, Zhang L, Ma JW. Computed tomography 3D reconstruction and texture analysis for evaluating the efficacy of neoadjuvant chemotherapy in advanced gastric cancer. World J Gastrointest Surg 2025; 17(6): 104545
- URL: https://www.wjgnet.com/1948-9366/full/v17/i6/104545.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i6.104545